WilliamJosephHoganMD

PubMed

• Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.
  Nickolas Steinauer, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Torghabeh, Mark R Litzow, Wi...> ;Haematologica. 2024 Mar 28
• Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant.
  Ayalew Tefferi, Animesh Pardanani, Kebede H Begna, Aref Al-Kali, William J Hogan, Mark R Litzow, Rhett P Ketterling, Kaaren K Reichard, Naseema Gangat> ;Blood Cancer Journal. 2024 Mar 19
• Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study.
  Svetlana Herasevich, Mehrdad Hefazi Torghabeh, Philip J Schulte, Hemang Yadav, Zhenmei Zhang, Bradley A White, William J Hogan, Alexander S Niven, Ognjen Gajic> ;Bone Marrow Transplantation. 2024 Mar 16
• Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms.
  Anmol Baranwal, Rami Basmaci, Rong He, Hemant S Murthy, Mehrdad Hefazi, Aref Al-Kali, Hassan B Alkhateeb, Greipp, P., Mangaonkar, A., Viswanatha, D., Foran, J., Palmer...> ;Blood Advances. 2024 Feb 13
• Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
  Isla M Johnson, Omer Karrar, Masooma Rana, Moazah Iftikhar, Sunny Chen, Kristen McCullough, Antoine N Saliba, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Mark Litzow...> ;British Journal of Haematology. 2024 Apr 1
• A Day 14 Endpoint for Acute GVHD Clinical Trials.
  Al Malki, M. M., Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo-Hiraldo, Monzr M Al Malki, Francis Ayuk, Peter Bader, Ja...> ;Transplantation and Cellular Therapy. 2024 Feb 4
• Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms.
  Baranwal, A., Gurney, M., Basmaci, R., Katamesh, B., He, R., Viswanatha, D., Greipp, P., Foran, J., Badar, T., Murthy, H., Yi, C., Palmer, J., Mangaonkar, A., Patnaik,...> ;Haematologica. 2024 Feb 1
• EASIX and CPSS Cytogenetics score-based composite risk model for patients with CMML undergoing allogeneic transplant.
  Anmol Baranwal, Abhishek Mangaonkar, Mithun V Shah, Aref Al-Kali, Ayalew Tefferi, William J Hogan, Mark R Litzow, Mrinal M Patnaik, Hassan B Alkhateeb> ;Bone Marrow Transplantation. 2024 Apr 1
• Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients.
  Heybati, K., Ochal, D., Al-Khateeb, H., Sklar, D., Herasevich, S., Torghabeh, M., Hogan, W., Litzow, M., Shah, M., Durani, U., Bauer, P., Gajic, O., Yadav, H.> ;Annals of Hematology. 2024 Mar 1
• 3 citations
  Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxi...
  Karrar, O., Abdelmagid, M., Rana, M., Iftikhar, M., McCullough, K., Al-Kali, A., Alkhateeb, H., Begna, K., Elliott, M., Mangaonkar, A., Saliba, A., Hefazi Torghabeh, M...> ;American Journal of Hematology. 2024 Feb 1
• 8 citations
  Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive...
  Gangat, N., Karrar, O., Iftikhar, M., McCullough, K., Johnson, I., Abdelmagid, M., Abdallah, M., Al-Kali, A., Alkhateeb, H., Begna, K., Mangaonkar, A., Saliba, A., Hef...> ;American Journal of Hematology. 2024 Feb 1
• 1 citations
  Lung Injury Prediction Model in Bone Marrow Transplantation: A Multicenter Cohort Study.
  Herasevich, S., Schulte, P., Hogan, W., Alkhateeb, H., Zhang, Z., Khera, N., Roy, V., Gajic, O., Yadav, H., White, B., Zhang, Z.> ;American Journal of Respiratory and Critical Care Medicine. 2024 Mar 1
• 2 citations
  Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.
  Ayalew Tefferi, Maymona Abdelmagid, Aref Al-Kali, Mrinal Patnaik, William J Hogan, Kebede Begna, Naseema Gangat, Attilio Orazi, Dong Chen, Kaaren K Reichard, Animesh P...> ;American Journal of Hematology. 2024 Jan 1
• 3 citations
  Mast cell cytomorphology and treatment outcome in mast cell leukemia.
  Ayalew Tefferi, Animesh Pardanani, Aref Al-Kali, Hassan Alkhateeb, Kristen McCullough, Mrinal Patnaik, William J Hogan, Kebede Begna, Michelle A Elliott, Nandita Khera...> ;American Journal of Hematology. 2024 Jan 1
• 3 citations
  Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients.
  Ahmad Nanaa, Rong He, James M Foran, Talha Badar, Naseema Gangat, Animesh Pardanani, William J Hogan, Mark R Litzow, Mrinal Patnaik, Aref Al-Kali, Hassan B Alkhateeb> ;British Journal of Haematology. 2024 Jan 1
• 1 citations
  The utility of biomarkers in acute GVHD prognostication.
  Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra, William J Hogan, Wolf Rösler, Elizabeth Hexner, Zachariah DeFilipp, Ran Reshef, Chan...> ;Blood Advances. 2023 Sep 12
• 4 citations
  Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
  Animesh Pardanani, Ayalew Tefferi, Aref Al-Kali, Mrinal Patnaik, William J Hogan, Kebede Begna, Michelle A Elliott, Nandita Khera, Jeanne M Palmer, Naseema Gangat, Att...> ;American Journal of Hematology. 2024 Jan 1
• Long-Term Pulmonary Function Trajectories After Allogeneic Bone Marrow Transplantation.
  Hemang Yadav, Mehrdad Hefazi Torghabeh, William J Hogan, Andrew H Limper> ;CHEST Pulmonary. 2023 Sep 1
• Pulmonary function and long-term survival in patients with PERDS after autologous hematopoietic stem cell transplantation.
  Zhenmei Zhang, Patrick M Wieruszewski, Mehrdad Hefazi Torghabeh, William J Hogan, Hemang Yadav> ;Bone Marrow Transplantation. 2023 Nov 1
• 1 citations
  Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.
  Yu Akahoshi, Nikolaos Spyrou, William J Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber, Hannah K Choe, Elizabeth O Hexner, Wolf Rösler, Aaron M Etra, Karamjeet...> ;Blood Advances. 2023 Aug 22
• 1 citations
  Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
  Walker M Schmidt, Nirosha D Perera, Francis K Buadi, Suzanne R Hayman, Shaji K Kumar, Angela Dispenzieri, David Dingli, Joselle Cook, Martha Q Lacy, Prashant Kapoor, N...> ;Blood Cancer Journal. 2023 Aug 18
• 1 citations
  Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arte...
  Maymona G Abdelmagid, Aref Al-Kali, Mark R Litzow, Kebede H Begna, William J Hogan, Mirinal S Patnaik, Shahrukh K Hashmi, Michelle A Elliott, Hassan Alkhateeb, Omer S ...> ;Blood Cancer Journal. 2023 Aug 11
• Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia.
  Naseema Gangat, Kristen McCullough, Maymona Abdelmagid, Omer Karrar, Marissa Powell, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek Mangaonkar, Antoine Saliba,...> ;Haematologica. 2024 Jan 1
• Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival.
  Naseema Gangat, Andrew Kuykendall, Najla Al Ali, Swati Goel, Maymona Abdelmagid, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Mark R Litzow, ...> ;Blood Advances. 2023 Jun 27
• 1 citations
  Prognostic Significance of Early Declines in Pulmonary Function After Allogeneic Hematopoietic Stem Cell Transplantation.
  Hemang Yadav, Mehrdad Hefazi Torghabeh, William J Hogan, Andrew H Limper> ;Respiratory Care. 2023 Oct 1
• Join now to see all

Journal Articles

• Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell Transplantation  
  Nelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
• Comparable Outcomes Using Propylene Glycol-Free Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma  
  Morie A Gertz, Shaji K Kumar, Martha Q Lacy, Prashant Kapoor, Suzanne R Hayman, Robert C Wolf, William J Hogan, Wilson I Gonsalves, Angela A Dispenzieri, David Dingli,..., Nature
• Does Matching for SNPs in the MHC Gamma Block in 10/10 HLA-Matched Unrelated Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant Improve Outcomes?  
  Eapen K Jacob, Shahrukh K Hashmi, Justin D Kreuter, William J Hogan, Dennis A Gastineau, Ann M Moyer, Mark Litzow, ScienceDirect
• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
• Join now to see all